FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder ...Middle East

Medscape - News
Lumasiran (Oxlumo) is the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder that causes recurrent kidney stones and loss of kidney function. FDA Approvals

Hence then, the article about fda clears first drug to treat ultra rare metabolic disorder was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug to Treat Ultra-Rare Metabolic Disorder )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News